Heathcote, E. Jenny
University of Toronto
15 papers on CoChat
Most cited papers
- Verified
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: A 5-year open-label follow-up study
Marcellin, P., Gane, E., Buti, M., Afdhal, N., Sievert, W., Jacobson, I. M., Washington, M. K., Germanidis, G., Flaherty, J. F., Schall, R. A., et al. (2013) · The Lancet
Hepatitis B Virus StudiesHepatitis C virus research
Cited by 1,788
- Verified
Primary Biliary Cirrhosis Associated with HLA, IL12A, and IL12RB2 Variants
Hirschfield, G. M., Liu, X., Xu, C., Lu, Y., Xie, G., Lu, Y., Gu, X., Walker, E. J., Jing, K., Juran, B. D., et al. (2009) · New England Journal of Medicine
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 594
- Verified
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis
Liu, X., Invernizzi, P., Lu, Y., Kosoy, R., Lu, Y., Bianchi, I., Podda, M., Xu, C., Xie, G., Macciardi, F., et al. (2010) · Nature Genetics
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 398
- Verified
Pathogenesis of cholestatic liver disease and therapeutic approaches
Hirschfield, G. M., Heathcote, E. J., & Gershwin, M. E. (2010) · Gastroenterology
Liver Diseases and ImmunityLiver physiology and pathology
Cited by 287
- Verified
Fatigue in primary biliary cirrhosis
Cauch-Dudek, K., Abbey, S., Stewart, D. E., & Heathcote, E. J. (1998) · Gut
Liver Diseases and ImmunityFibromyalgia and Chronic Fatigue Syndrome Research
Cited by 237
- Verified
Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis
Hirschfield, G. M., Liu, X., Han, Y., Gorlov, I. P., Lu, Y., Xu, C., Lu, Y., Chen, W., Juran, B. D., Coltescu, C., et al. (2010) · Nature Genetics
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 215
- Verified
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants
Juran, B. D., Hirschfield, G. M., Invernizzi, P., Atkinson, E. J., Li, Y., Xie, G., Kosoy, R., Ransom, M., Sun, Y., Bianchi, I., et al. (2012) · Human Molecular Genetics
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 150
- Verified
Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis
O'Brien, C., Joshi, S., Feld, J. J., Guindi, M., Dienes, H. P., & Heathcote, E. J. (2008) · Hepatology
Liver Diseases and ImmunityIgG4-Related and Inflammatory Diseases
Cited by 146
- Verified
Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis
Springer, J., Cauch-Dudek, K., O'Rourke, K., Wanless, I. R., & Heathcote, E. J. (1999) · American Journal of Gastroenterology
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 141
- Verified
PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis
Liu, H., Norman, G. L., Shums, Z., Worman, H. J., Krawitt, E. L., Bizzaro, N., Vergani, D., Bogdanos, D. P., Dalekos, G. N., Milkiewicz, P., et al. (2010) · Journal of Autoimmunity
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 130
- Verified
Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?
Kilmurry, M. R., Heathcote, E. J., Cauch-Dudek, K., O’Rourke, K., Bailey, R. J., Blendis, L. M., Ghent, C. N., Minuk, G. Y., Pappas, S. C., Scully, L. J., et al. (1996) · Hepatology
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 94
- Verified
Pediatric-onset primary biliary cirrhosis
Dahlan, Y., Smith, L., Simmonds, D., Jewell, L. D., Wanless, I., Heathcote, E. J., & Bain, V. G. (2003) · Gastroenterology
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 92
- Verified
A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue
Theal, J. J., Toosi, M. N., Girlan, L., Heslegrave, R. J., Huet, P., Burak, K. W., Swain, M., Tomlinson, G. A., & Heathcote, E. J. (2005) · Hepatology
Liver Diseases and ImmunityFibromyalgia and Chronic Fatigue Syndrome Research
Cited by 73
- Verified
Osteoporosis in Primary Biliary Cirrhosis: A Randomized Trial of the Efficacy and Feasibility of Estrogen/Progestin
Boone, R. H., Cheung, A. M., Girlan, L. M., & Heathcote, E. J. (2006) · Digestive Diseases and Sciences
Liver Diseases and ImmunityBone health and osteoporosis research
Cited by 54
- Verified
Role of Plasmapheresis in the Treatment of Severe Pruritus in Pregnant Patients with Primary Biliary Cirrhosis: Case Reports
Alallam, A., Barth, D., & Heathcote, E. J. (2008) · Canadian Journal of Gastroenterology
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 52
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free